ALRT Medication Reminder System Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ALRT Medication Reminder System

ALRT 0.0300

-4.5%

Nov 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JPhilipS who wrote (79)	8/29/1999 10:36:00 PM
From: Cosmo Daisey	Read Replies (1) of 102

J, I think everybody saw the news that the Pres resigned. It is my understanding that Mr. Eadie was an interim director and President and Mr. Lee Burg, the consultant was being offered the job. If this is the plan then I would expect an announcement pretty soon. As a courtesy to Mr. Eadie there will probably be a short delay so as not to appear as though Mr. Eadie was fired or pushed out. When the last President resigned the company wanted Mr. Burg but he wasn't able to accept the offer at the time. The only mention that Mr. Eadie was President was a note on the news release when Michael Best resigned June 9th. There never was a follow up release naming him Pres. or any other news about him. The current news release is signed by a director so aparently no one has filled the Pres seat. The company may still have a couple of directors left over and holding seats as the result of the merger that took place to form the company. Mr. Best is skilled at forming companies in this manner and wasn't expected to stay after his task was completed. If this clears the way for Mr. Berg then this is really exciting news. Her is a little info about Burg: """Mr. Lee Burg's successful career in the pharmaceutical industry has spanned a period of more than 35 years. His experience has included positions as Vice President of Managed Health Care for E.R. Squibb & Sons and Vice President of Marketing and Sales for the following companies: U.S.V. Laboratories, Armour Pharmaceutical Company and Wm. H. Rorer. Mr. Burg served as the General Manager of Apothecon from 1990 to 1997. Apothecon is a wholly owned subsidiary of Bristol-Myers Squibb and competes in the generic sector of the pharmaceutical industry. Under Mr. Burg's direction, between 1990 and 1996 annual sales increased from $120 million to $500 million and earnings increased from a nominal level to a pre tax profit of $225 million. """ Lets hang in there and see what happens. Cosmo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next